nodes	percent_of_prediction	percent_of_DWPC	metapath
Sorafenib—HTR2B—migraine	0.268	0.672	CbGaD
Sorafenib—HTR2C—migraine	0.131	0.328	CbGaD
Sorafenib—UGT1A9—Valproic Acid—migraine	0.032	0.0847	CbGbCtD
Sorafenib—ABCC4—Verapamil—migraine	0.0233	0.0617	CbGbCtD
Sorafenib—HTR2C—Amitriptyline—migraine	0.0179	0.0474	CbGbCtD
Sorafenib—ABCC2—Verapamil—migraine	0.0138	0.0367	CbGbCtD
Sorafenib—CYP3A7—Propranolol—migraine	0.0135	0.0357	CbGbCtD
Sorafenib—CYP3A7-CYP3A51P—Propranolol—migraine	0.0135	0.0357	CbGbCtD
Sorafenib—ABCG2—Verapamil—migraine	0.0125	0.0332	CbGbCtD
Sorafenib—CYP2B6—Amitriptyline—migraine	0.0111	0.0294	CbGbCtD
Sorafenib—CYP2B6—Valproic Acid—migraine	0.0101	0.0268	CbGbCtD
Sorafenib—CYP3A5—Propranolol—migraine	0.0101	0.0268	CbGbCtD
Sorafenib—CYP3A7—Verapamil—migraine	0.00924	0.0245	CbGbCtD
Sorafenib—CYP3A7-CYP3A51P—Verapamil—migraine	0.00924	0.0245	CbGbCtD
Sorafenib—CYP2C19—Timolol—migraine	0.00914	0.0242	CbGbCtD
Sorafenib—CYP2B6—Verapamil—migraine	0.0088	0.0233	CbGbCtD
Sorafenib—CYP3A5—Amitriptyline—migraine	0.00874	0.0232	CbGbCtD
Sorafenib—CYP2C8—Amitriptyline—migraine	0.0084	0.0223	CbGbCtD
Sorafenib—CYP2C19—Propranolol—migraine	0.00815	0.0216	CbGbCtD
Sorafenib—CYP3A5—Valproic Acid—migraine	0.00796	0.0211	CbGbCtD
Sorafenib—CYP2C8—Valproic Acid—migraine	0.00766	0.0203	CbGbCtD
Sorafenib—CYP1A2—Propranolol—migraine	0.00752	0.0199	CbGbCtD
Sorafenib—ABCB1—Timolol—migraine	0.00738	0.0195	CbGbCtD
Sorafenib—CYP2C19—Amitriptyline—migraine	0.00705	0.0187	CbGbCtD
Sorafenib—CYP2D6—Timolol—migraine	0.00695	0.0184	CbGbCtD
Sorafenib—CYP3A5—Verapamil—migraine	0.00693	0.0184	CbGbCtD
Sorafenib—CYP2C8—Verapamil—migraine	0.00667	0.0177	CbGbCtD
Sorafenib—ABCB1—Propranolol—migraine	0.00658	0.0174	CbGbCtD
Sorafenib—CYP1A2—Amitriptyline—migraine	0.0065	0.0172	CbGbCtD
Sorafenib—CYP2C19—Valproic Acid—migraine	0.00642	0.017	CbGbCtD
Sorafenib—CYP2D6—Propranolol—migraine	0.0062	0.0164	CbGbCtD
Sorafenib—CYP1A2—Valproic Acid—migraine	0.00593	0.0157	CbGbCtD
Sorafenib—CYP2C9—Amitriptyline—migraine	0.00586	0.0155	CbGbCtD
Sorafenib—CYP2C19—Topiramate—migraine	0.0058	0.0154	CbGbCtD
Sorafenib—ABCB1—Amitriptyline—migraine	0.00569	0.0151	CbGbCtD
Sorafenib—CYP2C19—Verapamil—migraine	0.00559	0.0148	CbGbCtD
Sorafenib—CYP2D6—Amitriptyline—migraine	0.00536	0.0142	CbGbCtD
Sorafenib—CYP2C9—Valproic Acid—migraine	0.00534	0.0142	CbGbCtD
Sorafenib—CYP1A2—Verapamil—migraine	0.00516	0.0137	CbGbCtD
Sorafenib—CYP2C9—Verapamil—migraine	0.00465	0.0123	CbGbCtD
Sorafenib—ABCB1—Verapamil—migraine	0.00451	0.012	CbGbCtD
Sorafenib—CYP2D6—Verapamil—migraine	0.00425	0.0113	CbGbCtD
Sorafenib—CYP3A4—Propranolol—migraine	0.00394	0.0104	CbGbCtD
Sorafenib—CYP3A4—Amitriptyline—migraine	0.00341	0.00903	CbGbCtD
Sorafenib—CYP3A4—Valproic Acid—migraine	0.00311	0.00823	CbGbCtD
Sorafenib—CYP3A4—Topiramate—migraine	0.0028	0.00743	CbGbCtD
Sorafenib—CYP3A4—Verapamil—migraine	0.0027	0.00717	CbGbCtD
Sorafenib—RET—autonomic nervous system—migraine	0.00174	0.0285	CbGeAlD
Sorafenib—MAPK15—brainstem—migraine	0.00125	0.0205	CbGeAlD
Sorafenib—CDKL3—cardiovascular system—migraine	0.00124	0.0203	CbGeAlD
Sorafenib—TIE1—blood vessel—migraine	0.00105	0.0173	CbGeAlD
Sorafenib—MUSK—nervous system—migraine	0.000891	0.0146	CbGeAlD
Sorafenib—FLT4—blood vessel—migraine	0.000871	0.0143	CbGeAlD
Sorafenib—MKNK1—Pindolol—Propranolol—migraine	0.000861	0.51	CbGdCrCtD
Sorafenib—CDK7—Terbinafine—Propranolol—migraine	0.000826	0.49	CbGdCrCtD
Sorafenib—CDKL2—head—migraine	0.000766	0.0126	CbGeAlD
Sorafenib—CDKL2—nervous system—migraine	0.000727	0.0119	CbGeAlD
Sorafenib—CDKL2—central nervous system—migraine	0.0007	0.0115	CbGeAlD
Sorafenib—MAPK15—head—migraine	0.00069	0.0113	CbGeAlD
Sorafenib—FLT1—blood vessel—migraine	0.000677	0.0111	CbGeAlD
Sorafenib—MAPK15—nervous system—migraine	0.000654	0.0107	CbGeAlD
Sorafenib—MAPK15—central nervous system—migraine	0.00063	0.0103	CbGeAlD
Sorafenib—CDKL3—brain—migraine	0.000607	0.00995	CbGeAlD
Sorafenib—KDR—blood vessel—migraine	0.000572	0.00938	CbGeAlD
Sorafenib—CDKL2—brain—migraine	0.000555	0.0091	CbGeAlD
Sorafenib—RET—neck—migraine	0.00055	0.00901	CbGeAlD
Sorafenib—FGFR1—trigeminal ganglion—migraine	0.000531	0.0087	CbGeAlD
Sorafenib—ZAK—cardiovascular system—migraine	0.000514	0.00842	CbGeAlD
Sorafenib—KIT—blood vessel—migraine	0.000507	0.00831	CbGeAlD
Sorafenib—HIPK3—cardiovascular system—migraine	0.000503	0.00824	CbGeAlD
Sorafenib—MAP3K7—trigeminal ganglion—migraine	0.000502	0.00823	CbGeAlD
Sorafenib—MAPK15—brain—migraine	0.0005	0.0082	CbGeAlD
Sorafenib—PDGFRB—blood vessel—migraine	0.000495	0.00812	CbGeAlD
Sorafenib—MKNK2—trigeminal ganglion—migraine	0.000487	0.00798	CbGeAlD
Sorafenib—FLT1—neck—migraine	0.000484	0.00794	CbGeAlD
Sorafenib—RAF1—neck—migraine	0.000481	0.00789	CbGeAlD
Sorafenib—MKNK1—trigeminal ganglion—migraine	0.000481	0.00788	CbGeAlD
Sorafenib—RET—trigeminal ganglion—migraine	0.000475	0.00778	CbGeAlD
Sorafenib—TIE1—cardiovascular system—migraine	0.00047	0.0077	CbGeAlD
Sorafenib—RALBP1—trigeminal ganglion—migraine	0.00044	0.00721	CbGeAlD
Sorafenib—FLT3—cardiovascular system—migraine	0.000428	0.00701	CbGeAlD
Sorafenib—FLT1—trigeminal ganglion—migraine	0.000418	0.00685	CbGeAlD
Sorafenib—RAF1—trigeminal ganglion—migraine	0.000416	0.00681	CbGeAlD
Sorafenib—EPHB6—trigeminal ganglion—migraine	0.000413	0.00677	CbGeAlD
Sorafenib—KDR—neck—migraine	0.000409	0.00671	CbGeAlD
Sorafenib—MAPK11—head—migraine	0.000409	0.00671	CbGeAlD
Sorafenib—CDK7—head—migraine	0.000403	0.0066	CbGeAlD
Sorafenib—AURKC—head—migraine	0.000396	0.0065	CbGeAlD
Sorafenib—STK10—trigeminal ganglion—migraine	0.000396	0.00649	CbGeAlD
Sorafenib—FLT4—cardiovascular system—migraine	0.000388	0.00637	CbGeAlD
Sorafenib—MAPK11—nervous system—migraine	0.000388	0.00636	CbGeAlD
Sorafenib—CDK7—nervous system—migraine	0.000382	0.00626	CbGeAlD
Sorafenib—AURKC—nervous system—migraine	0.000376	0.00616	CbGeAlD
Sorafenib—MAPK11—central nervous system—migraine	0.000374	0.00612	CbGeAlD
Sorafenib—RAF1—brainstem—migraine	0.000368	0.00603	CbGeAlD
Sorafenib—CDK7—central nervous system—migraine	0.000368	0.00602	CbGeAlD
Sorafenib—EPHA6—head—migraine	0.000367	0.00602	CbGeAlD
Sorafenib—MAPK11—cerebellum—migraine	0.000365	0.00598	CbGeAlD
Sorafenib—KIT—neck—migraine	0.000363	0.00595	CbGeAlD
Sorafenib—AURKC—central nervous system—migraine	0.000362	0.00593	CbGeAlD
Sorafenib—CDK7—cerebellum—migraine	0.000359	0.00589	CbGeAlD
Sorafenib—TAOK2—cerebellum—migraine	0.000356	0.00584	CbGeAlD
Sorafenib—PDGFRB—neck—migraine	0.000354	0.00581	CbGeAlD
Sorafenib—MAP2K5—trigeminal ganglion—migraine	0.000353	0.00579	CbGeAlD
Sorafenib—KDR—trigeminal ganglion—migraine	0.000353	0.00579	CbGeAlD
Sorafenib—MKNK2—cardiovascular system—migraine	0.000352	0.00576	CbGeAlD
Sorafenib—EPHA6—nervous system—migraine	0.000348	0.0057	CbGeAlD
Sorafenib—ZAK—head—migraine	0.000348	0.0057	CbGeAlD
Sorafenib—MKNK1—cardiovascular system—migraine	0.000347	0.00569	CbGeAlD
Sorafenib—CSF1R—trigeminal ganglion—migraine	0.000345	0.00565	CbGeAlD
Sorafenib—HIPK4—brain—migraine	0.000337	0.00552	CbGeAlD
Sorafenib—EPHA6—central nervous system—migraine	0.000335	0.00549	CbGeAlD
Sorafenib—MAP3K19—head—migraine	0.000334	0.00547	CbGeAlD
Sorafenib—ZAK—nervous system—migraine	0.00033	0.00541	CbGeAlD
Sorafenib—TIE1—head—migraine	0.000318	0.00522	CbGeAlD
Sorafenib—ZAK—central nervous system—migraine	0.000318	0.00521	CbGeAlD
Sorafenib—RALBP1—cardiovascular system—migraine	0.000317	0.0052	CbGeAlD
Sorafenib—MAP3K19—nervous system—migraine	0.000316	0.00518	CbGeAlD
Sorafenib—KIT—trigeminal ganglion—migraine	0.000313	0.00513	CbGeAlD
Sorafenib—MAP2K5—brainstem—migraine	0.000313	0.00513	CbGeAlD
Sorafenib—ZAK—cerebellum—migraine	0.00031	0.00509	CbGeAlD
Sorafenib—PDGFRB—trigeminal ganglion—migraine	0.000306	0.00501	CbGeAlD
Sorafenib—MAP3K19—central nervous system—migraine	0.000305	0.00499	CbGeAlD
Sorafenib—HIPK3—cerebellum—migraine	0.000304	0.00498	CbGeAlD
Sorafenib—FLT1—cardiovascular system—migraine	0.000302	0.00495	CbGeAlD
Sorafenib—TIE1—nervous system—migraine	0.000302	0.00495	CbGeAlD
Sorafenib—RAF1—cardiovascular system—migraine	0.0003	0.00492	CbGeAlD
Sorafenib—MAPK11—brain—migraine	0.000297	0.00486	CbGeAlD
Sorafenib—CDK7—brain—migraine	0.000292	0.00478	CbGeAlD
Sorafenib—TIE1—central nervous system—migraine	0.000291	0.00476	CbGeAlD
Sorafenib—TAOK2—brain—migraine	0.000289	0.00474	CbGeAlD
Sorafenib—AURKC—brain—migraine	0.000287	0.00471	CbGeAlD
Sorafenib—STK10—cardiovascular system—migraine	0.000286	0.00469	CbGeAlD
Sorafenib—TIE1—cerebellum—migraine	0.000284	0.00465	CbGeAlD
Sorafenib—PDGFRA—cardiovascular system—migraine	0.000283	0.00464	CbGeAlD
Sorafenib—KIT—brainstem—migraine	0.000277	0.00454	CbGeAlD
Sorafenib—BRAF—cerebellum—migraine	0.000272	0.00446	CbGeAlD
Sorafenib—EPHA6—brain—migraine	0.000266	0.00436	CbGeAlD
Sorafenib—FLT4—head—migraine	0.000263	0.00431	CbGeAlD
Sorafenib—EPHX2—cerebellum—migraine	0.00026	0.00426	CbGeAlD
Sorafenib—FLT3—cerebellum—migraine	0.000258	0.00423	CbGeAlD
Sorafenib—MAP2K5—cardiovascular system—migraine	0.000255	0.00418	CbGeAlD
Sorafenib—KDR—cardiovascular system—migraine	0.000255	0.00418	CbGeAlD
Sorafenib—ZAK—brain—migraine	0.000252	0.00413	CbGeAlD
Sorafenib—CSF1R—cardiovascular system—migraine	0.000249	0.00408	CbGeAlD
Sorafenib—HIPK3—brain—migraine	0.000247	0.00404	CbGeAlD
Sorafenib—MAP3K19—brain—migraine	0.000242	0.00396	CbGeAlD
Sorafenib—MKNK2—head—migraine	0.000238	0.0039	CbGeAlD
Sorafenib—MKNK1—head—migraine	0.000235	0.00385	CbGeAlD
Sorafenib—RET—head—migraine	0.000232	0.00381	CbGeAlD
Sorafenib—FGFR1—cerebellum—migraine	0.000231	0.00379	CbGeAlD
Sorafenib—TIE1—brain—migraine	0.000231	0.00378	CbGeAlD
Sorafenib—HTR2C—brainstem—migraine	0.000228	0.00374	CbGeAlD
Sorafenib—KIT—cardiovascular system—migraine	0.000226	0.00371	CbGeAlD
Sorafenib—MKNK2—nervous system—migraine	0.000226	0.0037	CbGeAlD
Sorafenib—MKNK1—nervous system—migraine	0.000223	0.00365	CbGeAlD
Sorafenib—BRAF—brain—migraine	0.000221	0.00362	CbGeAlD
Sorafenib—PDGFRB—cardiovascular system—migraine	0.000221	0.00362	CbGeAlD
Sorafenib—RET—nervous system—migraine	0.00022	0.00361	CbGeAlD
Sorafenib—MAP3K7—cerebellum—migraine	0.000219	0.00359	CbGeAlD
Sorafenib—MKNK2—central nervous system—migraine	0.000217	0.00356	CbGeAlD
Sorafenib—RALBP1—head—migraine	0.000215	0.00352	CbGeAlD
Sorafenib—MKNK1—central nervous system—migraine	0.000215	0.00352	CbGeAlD
Sorafenib—MKNK2—cerebellum—migraine	0.000212	0.00348	CbGeAlD
Sorafenib—RET—central nervous system—migraine	0.000212	0.00347	CbGeAlD
Sorafenib—EPHX2—brain—migraine	0.000211	0.00346	CbGeAlD
Sorafenib—MKNK1—cerebellum—migraine	0.00021	0.00344	CbGeAlD
Sorafenib—RET—cerebellum—migraine	0.000207	0.0034	CbGeAlD
Sorafenib—FLT1—head—migraine	0.000204	0.00335	CbGeAlD
Sorafenib—RALBP1—nervous system—migraine	0.000204	0.00334	CbGeAlD
Sorafenib—RAF1—head—migraine	0.000203	0.00333	CbGeAlD
Sorafenib—EPHB6—head—migraine	0.000202	0.00331	CbGeAlD
Sorafenib—RALBP1—central nervous system—migraine	0.000196	0.00322	CbGeAlD
Sorafenib—FLT1—nervous system—migraine	0.000194	0.00318	CbGeAlD
Sorafenib—STK10—head—migraine	0.000194	0.00317	CbGeAlD
Sorafenib—RAF1—nervous system—migraine	0.000193	0.00316	CbGeAlD
Sorafenib—RALBP1—cerebellum—migraine	0.000192	0.00314	CbGeAlD
Sorafenib—EPHB6—nervous system—migraine	0.000192	0.00314	CbGeAlD
Sorafenib—PDGFRA—head—migraine	0.000192	0.00314	CbGeAlD
Sorafenib—FLT4—brain—migraine	0.000191	0.00312	CbGeAlD
Sorafenib—FGFR1—brain—migraine	0.000188	0.00308	CbGeAlD
Sorafenib—FLT1—central nervous system—migraine	0.000187	0.00306	CbGeAlD
Sorafenib—RAF1—central nervous system—migraine	0.000186	0.00304	CbGeAlD
Sorafenib—EPHB6—central nervous system—migraine	0.000185	0.00302	CbGeAlD
Sorafenib—STK10—nervous system—migraine	0.000184	0.00301	CbGeAlD
Sorafenib—FLT1—cerebellum—migraine	0.000182	0.00299	CbGeAlD
Sorafenib—PDGFRA—nervous system—migraine	0.000182	0.00298	CbGeAlD
Sorafenib—RAF1—cerebellum—migraine	0.000181	0.00297	CbGeAlD
Sorafenib—EPHB6—cerebellum—migraine	0.00018	0.00296	CbGeAlD
Sorafenib—MAP3K7—brain—migraine	0.000178	0.00292	CbGeAlD
Sorafenib—STK10—central nervous system—migraine	0.000177	0.0029	CbGeAlD
Sorafenib—HTR2B—cardiovascular system—migraine	0.000175	0.00287	CbGeAlD
Sorafenib—PDGFRA—central nervous system—migraine	0.000175	0.00287	CbGeAlD
Sorafenib—MAP2K5—head—migraine	0.000173	0.00283	CbGeAlD
Sorafenib—KDR—head—migraine	0.000173	0.00283	CbGeAlD
Sorafenib—STK10—cerebellum—migraine	0.000173	0.00283	CbGeAlD
Sorafenib—MKNK2—brain—migraine	0.000173	0.00283	CbGeAlD
Sorafenib—ABCG2—trigeminal ganglion—migraine	0.000172	0.00282	CbGeAlD
Sorafenib—PDGFRA—cerebellum—migraine	0.000171	0.0028	CbGeAlD
Sorafenib—MKNK1—brain—migraine	0.00017	0.00279	CbGeAlD
Sorafenib—CSF1R—head—migraine	0.000169	0.00277	CbGeAlD
Sorafenib—RET—brain—migraine	0.000168	0.00276	CbGeAlD
Sorafenib—KDR—nervous system—migraine	0.000164	0.00269	CbGeAlD
Sorafenib—MAP2K5—nervous system—migraine	0.000164	0.00269	CbGeAlD
Sorafenib—Alanine aminotransferase increased—Topiramate—migraine	0.000163	0.00165	CcSEcCtD
Sorafenib—Dizziness—Amitriptyline—migraine	0.000162	0.00164	CcSEcCtD
Sorafenib—Alopecia—Valproic Acid—migraine	0.000162	0.00164	CcSEcCtD
Sorafenib—Dyspepsia—Verapamil—migraine	0.000161	0.00163	CcSEcCtD
Sorafenib—Mental disorder—Valproic Acid—migraine	0.00016	0.00162	CcSEcCtD
Sorafenib—Connective tissue disorder—Timolol—migraine	0.00016	0.00162	CcSEcCtD
Sorafenib—CSF1R—nervous system—migraine	0.00016	0.00262	CbGeAlD
Sorafenib—Hepatobiliary disease—Gabapentin—migraine	0.00016	0.00162	CcSEcCtD
Sorafenib—Dysphagia—Topiramate—migraine	0.000159	0.00161	CcSEcCtD
Sorafenib—Epistaxis—Gabapentin—migraine	0.000159	0.00161	CcSEcCtD
Sorafenib—Malnutrition—Valproic Acid—migraine	0.000159	0.00161	CcSEcCtD
Sorafenib—Urticaria—Propranolol—migraine	0.000158	0.0016	CcSEcCtD
Sorafenib—Fatigue—Verapamil—migraine	0.000158	0.0016	CcSEcCtD
Sorafenib—KDR—central nervous system—migraine	0.000158	0.00259	CbGeAlD
Sorafenib—MAP2K5—central nervous system—migraine	0.000158	0.00259	CbGeAlD
Sorafenib—Body temperature increased—Propranolol—migraine	0.000158	0.00159	CcSEcCtD
Sorafenib—Abdominal pain—Propranolol—migraine	0.000158	0.00159	CcSEcCtD
Sorafenib—Pain—Verapamil—migraine	0.000157	0.00159	CcSEcCtD
Sorafenib—Constipation—Verapamil—migraine	0.000157	0.00159	CcSEcCtD
Sorafenib—Pancreatitis—Topiramate—migraine	0.000156	0.00158	CcSEcCtD
Sorafenib—Dysgeusia—Valproic Acid—migraine	0.000156	0.00158	CcSEcCtD
Sorafenib—RALBP1—brain—migraine	0.000156	0.00255	CbGeAlD
Sorafenib—Vomiting—Amitriptyline—migraine	0.000156	0.00157	CcSEcCtD
Sorafenib—Rash—Amitriptyline—migraine	0.000154	0.00156	CcSEcCtD
Sorafenib—KDR—cerebellum—migraine	0.000154	0.00253	CbGeAlD
Sorafenib—MAP2K5—cerebellum—migraine	0.000154	0.00253	CbGeAlD
Sorafenib—Dermatitis—Amitriptyline—migraine	0.000154	0.00156	CcSEcCtD
Sorafenib—CSF1R—central nervous system—migraine	0.000154	0.00252	CbGeAlD
Sorafenib—Headache—Amitriptyline—migraine	0.000153	0.00155	CcSEcCtD
Sorafenib—KIT—head—migraine	0.000153	0.00251	CbGeAlD
Sorafenib—Muscle spasms—Valproic Acid—migraine	0.000153	0.00155	CcSEcCtD
Sorafenib—Abdominal discomfort—Topiramate—migraine	0.000153	0.00155	CcSEcCtD
Sorafenib—Tinnitus—Timolol—migraine	0.000152	0.00154	CcSEcCtD
Sorafenib—Haemorrhage—Gabapentin—migraine	0.000152	0.00153	CcSEcCtD
Sorafenib—Cardiac disorder—Timolol—migraine	0.000151	0.00153	CcSEcCtD
Sorafenib—CSF1R—cerebellum—migraine	0.000151	0.00247	CbGeAlD
Sorafenib—Urinary tract disorder—Gabapentin—migraine	0.00015	0.00152	CcSEcCtD
Sorafenib—PDGFRB—head—migraine	0.00015	0.00245	CbGeAlD
Sorafenib—Neutropenia—Topiramate—migraine	0.000149	0.00151	CcSEcCtD
Sorafenib—Connective tissue disorder—Gabapentin—migraine	0.000149	0.00151	CcSEcCtD
Sorafenib—Urethral disorder—Gabapentin—migraine	0.000149	0.0015	CcSEcCtD
Sorafenib—FLT1—brain—migraine	0.000148	0.00243	CbGeAlD
Sorafenib—Angiopathy—Timolol—migraine	0.000148	0.0015	CcSEcCtD
Sorafenib—RAF1—brain—migraine	0.000147	0.00241	CbGeAlD
Sorafenib—Anaemia—Valproic Acid—migraine	0.000147	0.00149	CcSEcCtD
Sorafenib—Immune system disorder—Timolol—migraine	0.000147	0.00149	CcSEcCtD
Sorafenib—Hypersensitivity—Propranolol—migraine	0.000147	0.00149	CcSEcCtD
Sorafenib—Erectile dysfunction—Topiramate—migraine	0.000147	0.00149	CcSEcCtD
Sorafenib—Mediastinal disorder—Timolol—migraine	0.000147	0.00149	CcSEcCtD
Sorafenib—EPHB6—brain—migraine	0.000146	0.0024	CbGeAlD
Sorafenib—Urticaria—Verapamil—migraine	0.000146	0.00147	CcSEcCtD
Sorafenib—Angioedema—Valproic Acid—migraine	0.000146	0.00147	CcSEcCtD
Sorafenib—Arrhythmia—Timolol—migraine	0.000146	0.00147	CcSEcCtD
Sorafenib—Nausea—Amitriptyline—migraine	0.000145	0.00147	CcSEcCtD
Sorafenib—KIT—nervous system—migraine	0.000145	0.00238	CbGeAlD
Sorafenib—Weight decreased—Topiramate—migraine	0.000144	0.00146	CcSEcCtD
Sorafenib—Alopecia—Timolol—migraine	0.000144	0.00146	CcSEcCtD
Sorafenib—Erythema multiforme—Gabapentin—migraine	0.000143	0.00145	CcSEcCtD
Sorafenib—Asthenia—Propranolol—migraine	0.000143	0.00145	CcSEcCtD
Sorafenib—Pneumonia—Topiramate—migraine	0.000143	0.00145	CcSEcCtD
Sorafenib—Mental disorder—Timolol—migraine	0.000143	0.00144	CcSEcCtD
Sorafenib—Leukopenia—Valproic Acid—migraine	0.000143	0.00144	CcSEcCtD
Sorafenib—Infestation NOS—Topiramate—migraine	0.000142	0.00144	CcSEcCtD
Sorafenib—Infestation—Topiramate—migraine	0.000142	0.00144	CcSEcCtD
Sorafenib—PDGFRB—nervous system—migraine	0.000142	0.00233	CbGeAlD
Sorafenib—Malnutrition—Timolol—migraine	0.000142	0.00143	CcSEcCtD
Sorafenib—Erythema—Timolol—migraine	0.000142	0.00143	CcSEcCtD
Sorafenib—Tinnitus—Gabapentin—migraine	0.000141	0.00143	CcSEcCtD
Sorafenib—Stevens-Johnson syndrome—Topiramate—migraine	0.000141	0.00143	CcSEcCtD
Sorafenib—Cardiac disorder—Gabapentin—migraine	0.000141	0.00142	CcSEcCtD
Sorafenib—STK10—brain—migraine	0.00014	0.0023	CbGeAlD
Sorafenib—KIT—central nervous system—migraine	0.00014	0.00229	CbGeAlD
Sorafenib—Renal failure—Topiramate—migraine	0.00014	0.00141	CcSEcCtD
Sorafenib—Neuropathy peripheral—Topiramate—migraine	0.000139	0.00141	CcSEcCtD
Sorafenib—Cough—Valproic Acid—migraine	0.000139	0.00141	CcSEcCtD
Sorafenib—PDGFRA—brain—migraine	0.000139	0.00228	CbGeAlD
Sorafenib—Dysgeusia—Timolol—migraine	0.000139	0.0014	CcSEcCtD
Sorafenib—Stomatitis—Topiramate—migraine	0.000139	0.0014	CcSEcCtD
Sorafenib—Hypertension—Valproic Acid—migraine	0.000138	0.00139	CcSEcCtD
Sorafenib—ABCB1—blood vessel—migraine	0.000137	0.00225	CbGeAlD
Sorafenib—Immune system disorder—Gabapentin—migraine	0.000137	0.00139	CcSEcCtD
Sorafenib—Mediastinal disorder—Gabapentin—migraine	0.000137	0.00138	CcSEcCtD
Sorafenib—KIT—cerebellum—migraine	0.000137	0.00224	CbGeAlD
Sorafenib—PDGFRB—central nervous system—migraine	0.000137	0.00224	CbGeAlD
Sorafenib—Diarrhoea—Propranolol—migraine	0.000136	0.00138	CcSEcCtD
Sorafenib—Myalgia—Valproic Acid—migraine	0.000136	0.00137	CcSEcCtD
Sorafenib—Arthralgia—Valproic Acid—migraine	0.000136	0.00137	CcSEcCtD
Sorafenib—Hypersensitivity—Verapamil—migraine	0.000135	0.00137	CcSEcCtD
Sorafenib—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000135	0.00136	CcSEcCtD
Sorafenib—Epistaxis—Topiramate—migraine	0.000134	0.00136	CcSEcCtD
Sorafenib—Alopecia—Gabapentin—migraine	0.000134	0.00136	CcSEcCtD
Sorafenib—PDGFRB—cerebellum—migraine	0.000133	0.00219	CbGeAlD
Sorafenib—Mental disorder—Gabapentin—migraine	0.000133	0.00134	CcSEcCtD
Sorafenib—Dry mouth—Valproic Acid—migraine	0.000133	0.00134	CcSEcCtD
Sorafenib—Erythema—Gabapentin—migraine	0.000132	0.00134	CcSEcCtD
Sorafenib—Malnutrition—Gabapentin—migraine	0.000132	0.00134	CcSEcCtD
Sorafenib—Dizziness—Propranolol—migraine	0.000132	0.00133	CcSEcCtD
Sorafenib—Asthenia—Verapamil—migraine	0.000132	0.00133	CcSEcCtD
Sorafenib—Anaphylactic shock—Valproic Acid—migraine	0.00013	0.00132	CcSEcCtD
Sorafenib—Pruritus—Verapamil—migraine	0.00013	0.00131	CcSEcCtD
Sorafenib—Angioedema—Timolol—migraine	0.00013	0.00131	CcSEcCtD
Sorafenib—Dysgeusia—Gabapentin—migraine	0.000129	0.00131	CcSEcCtD
Sorafenib—Infection—Valproic Acid—migraine	0.000129	0.00131	CcSEcCtD
Sorafenib—Haemoglobin—Topiramate—migraine	0.000128	0.0013	CcSEcCtD
Sorafenib—Haemorrhage—Topiramate—migraine	0.000128	0.00129	CcSEcCtD
Sorafenib—Nervous system disorder—Valproic Acid—migraine	0.000127	0.00129	CcSEcCtD
Sorafenib—Thrombocytopenia—Valproic Acid—migraine	0.000127	0.00129	CcSEcCtD
Sorafenib—Syncope—Timolol—migraine	0.000127	0.00129	CcSEcCtD
Sorafenib—Muscle spasms—Gabapentin—migraine	0.000127	0.00128	CcSEcCtD
Sorafenib—Vomiting—Propranolol—migraine	0.000127	0.00128	CcSEcCtD
Sorafenib—Skin disorder—Valproic Acid—migraine	0.000126	0.00128	CcSEcCtD
Sorafenib—HTR2C—head—migraine	0.000126	0.00207	CbGeAlD
Sorafenib—Urinary tract disorder—Topiramate—migraine	0.000126	0.00128	CcSEcCtD
Sorafenib—Rash—Propranolol—migraine	0.000126	0.00127	CcSEcCtD
Sorafenib—Dermatitis—Propranolol—migraine	0.000126	0.00127	CcSEcCtD
Sorafenib—Diarrhoea—Verapamil—migraine	0.000125	0.00127	CcSEcCtD
Sorafenib—Connective tissue disorder—Topiramate—migraine	0.000125	0.00127	CcSEcCtD
Sorafenib—MAP2K5—brain—migraine	0.000125	0.00205	CbGeAlD
Sorafenib—KDR—brain—migraine	0.000125	0.00205	CbGeAlD
Sorafenib—Urethral disorder—Topiramate—migraine	0.000125	0.00127	CcSEcCtD
Sorafenib—Loss of consciousness—Timolol—migraine	0.000125	0.00126	CcSEcCtD
Sorafenib—Anorexia—Valproic Acid—migraine	0.000124	0.00125	CcSEcCtD
Sorafenib—Cough—Timolol—migraine	0.000124	0.00125	CcSEcCtD
Sorafenib—Hypertension—Timolol—migraine	0.000122	0.00124	CcSEcCtD
Sorafenib—CSF1R—brain—migraine	0.000122	0.002	CbGeAlD
Sorafenib—Anaemia—Gabapentin—migraine	0.000122	0.00123	CcSEcCtD
Sorafenib—Dizziness—Verapamil—migraine	0.000121	0.00123	CcSEcCtD
Sorafenib—Arthralgia—Timolol—migraine	0.000121	0.00122	CcSEcCtD
Sorafenib—Myalgia—Timolol—migraine	0.000121	0.00122	CcSEcCtD
Sorafenib—Erythema multiforme—Topiramate—migraine	0.000121	0.00122	CcSEcCtD
Sorafenib—Angioedema—Gabapentin—migraine	0.000121	0.00122	CcSEcCtD
Sorafenib—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.00012	0.00121	CcSEcCtD
Sorafenib—HTR2C—nervous system—migraine	0.00012	0.00196	CbGeAlD
Sorafenib—ABCC4—head—migraine	0.000119	0.00195	CbGeAlD
Sorafenib—Tinnitus—Topiramate—migraine	0.000119	0.0012	CcSEcCtD
Sorafenib—HTR2B—head—migraine	0.000119	0.00194	CbGeAlD
Sorafenib—Musculoskeletal discomfort—Valproic Acid—migraine	0.000118	0.0012	CcSEcCtD
Sorafenib—Cardiac disorder—Topiramate—migraine	0.000118	0.0012	CcSEcCtD
Sorafenib—Flushing—Topiramate—migraine	0.000118	0.0012	CcSEcCtD
Sorafenib—Syncope—Gabapentin—migraine	0.000118	0.0012	CcSEcCtD
Sorafenib—Nausea—Propranolol—migraine	0.000118	0.0012	CcSEcCtD
Sorafenib—Leukopenia—Gabapentin—migraine	0.000118	0.0012	CcSEcCtD
Sorafenib—Dry mouth—Timolol—migraine	0.000118	0.00119	CcSEcCtD
Sorafenib—Vomiting—Verapamil—migraine	0.000117	0.00118	CcSEcCtD
Sorafenib—Loss of consciousness—Gabapentin—migraine	0.000116	0.00117	CcSEcCtD
Sorafenib—Dyspnoea—Valproic Acid—migraine	0.000116	0.00117	CcSEcCtD
Sorafenib—Angiopathy—Topiramate—migraine	0.000116	0.00117	CcSEcCtD
Sorafenib—Anaphylactic shock—Timolol—migraine	0.000116	0.00117	CcSEcCtD
Sorafenib—Rash—Verapamil—migraine	0.000116	0.00117	CcSEcCtD
Sorafenib—Dermatitis—Verapamil—migraine	0.000115	0.00117	CcSEcCtD
Sorafenib—Immune system disorder—Topiramate—migraine	0.000115	0.00117	CcSEcCtD
Sorafenib—Cough—Gabapentin—migraine	0.000115	0.00117	CcSEcCtD
Sorafenib—HTR2C—central nervous system—migraine	0.000115	0.00189	CbGeAlD
Sorafenib—Mediastinal disorder—Topiramate—migraine	0.000115	0.00116	CcSEcCtD
Sorafenib—Infection—Timolol—migraine	0.000115	0.00116	CcSEcCtD
Sorafenib—Headache—Verapamil—migraine	0.000115	0.00116	CcSEcCtD
Sorafenib—CYP2B6—cardiovascular system—migraine	0.000115	0.00188	CbGeAlD
Sorafenib—Dyspepsia—Valproic Acid—migraine	0.000114	0.00116	CcSEcCtD
Sorafenib—Hypertension—Gabapentin—migraine	0.000114	0.00115	CcSEcCtD
Sorafenib—Shock—Timolol—migraine	0.000114	0.00115	CcSEcCtD
Sorafenib—Nervous system disorder—Timolol—migraine	0.000113	0.00115	CcSEcCtD
Sorafenib—CYP2C9—cardiovascular system—migraine	0.000113	0.00186	CbGeAlD
Sorafenib—Decreased appetite—Valproic Acid—migraine	0.000113	0.00114	CcSEcCtD
Sorafenib—ABCC4—nervous system—migraine	0.000113	0.00185	CbGeAlD
Sorafenib—Alopecia—Topiramate—migraine	0.000113	0.00114	CcSEcCtD
Sorafenib—Arthralgia—Gabapentin—migraine	0.000112	0.00114	CcSEcCtD
Sorafenib—Myalgia—Gabapentin—migraine	0.000112	0.00114	CcSEcCtD
Sorafenib—Skin disorder—Timolol—migraine	0.000112	0.00114	CcSEcCtD
Sorafenib—HTR2B—nervous system—migraine	0.000112	0.00184	CbGeAlD
Sorafenib—Gastrointestinal disorder—Valproic Acid—migraine	0.000112	0.00114	CcSEcCtD
Sorafenib—Fatigue—Valproic Acid—migraine	0.000112	0.00113	CcSEcCtD
Sorafenib—Mental disorder—Topiramate—migraine	0.000112	0.00113	CcSEcCtD
Sorafenib—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000112	0.00113	CcSEcCtD
Sorafenib—Constipation—Valproic Acid—migraine	0.000111	0.00112	CcSEcCtD
Sorafenib—Pain—Valproic Acid—migraine	0.000111	0.00112	CcSEcCtD
Sorafenib—Erythema—Topiramate—migraine	0.000111	0.00112	CcSEcCtD
Sorafenib—Malnutrition—Topiramate—migraine	0.000111	0.00112	CcSEcCtD
Sorafenib—KIT—brain—migraine	0.000111	0.00182	CbGeAlD
Sorafenib—Anorexia—Timolol—migraine	0.00011	0.00112	CcSEcCtD
Sorafenib—Dry mouth—Gabapentin—migraine	0.00011	0.00111	CcSEcCtD
Sorafenib—Nausea—Verapamil—migraine	0.000109	0.0011	CcSEcCtD
Sorafenib—Dysgeusia—Topiramate—migraine	0.000109	0.0011	CcSEcCtD
Sorafenib—ABCC4—central nervous system—migraine	0.000109	0.00178	CbGeAlD
Sorafenib—PDGFRB—brain—migraine	0.000108	0.00178	CbGeAlD
Sorafenib—HTR2B—central nervous system—migraine	0.000108	0.00177	CbGeAlD
Sorafenib—Anaphylactic shock—Gabapentin—migraine	0.000108	0.00109	CcSEcCtD
Sorafenib—Infection—Gabapentin—migraine	0.000107	0.00108	CcSEcCtD
Sorafenib—Muscle spasms—Topiramate—migraine	0.000107	0.00108	CcSEcCtD
Sorafenib—Gastrointestinal pain—Valproic Acid—migraine	0.000106	0.00108	CcSEcCtD
Sorafenib—Shock—Gabapentin—migraine	0.000106	0.00107	CcSEcCtD
Sorafenib—Nervous system disorder—Gabapentin—migraine	0.000106	0.00107	CcSEcCtD
Sorafenib—Thrombocytopenia—Gabapentin—migraine	0.000106	0.00107	CcSEcCtD
Sorafenib—Musculoskeletal discomfort—Timolol—migraine	0.000105	0.00107	CcSEcCtD
Sorafenib—Skin disorder—Gabapentin—migraine	0.000105	0.00106	CcSEcCtD
Sorafenib—CYP2D6—brainstem—migraine	0.000104	0.00171	CbGeAlD
Sorafenib—Urticaria—Valproic Acid—migraine	0.000103	0.00104	CcSEcCtD
Sorafenib—Dyspnoea—Timolol—migraine	0.000103	0.00104	CcSEcCtD
Sorafenib—Body temperature increased—Valproic Acid—migraine	0.000103	0.00104	CcSEcCtD
Sorafenib—Abdominal pain—Valproic Acid—migraine	0.000103	0.00104	CcSEcCtD
Sorafenib—Anorexia—Gabapentin—migraine	0.000103	0.00104	CcSEcCtD
Sorafenib—Anaemia—Topiramate—migraine	0.000103	0.00104	CcSEcCtD
Sorafenib—Dyspepsia—Timolol—migraine	0.000102	0.00103	CcSEcCtD
Sorafenib—Decreased appetite—Timolol—migraine	0.000101	0.00102	CcSEcCtD
Sorafenib—Gastrointestinal disorder—Timolol—migraine	9.99e-05	0.00101	CcSEcCtD
Sorafenib—Fatigue—Timolol—migraine	9.98e-05	0.00101	CcSEcCtD
Sorafenib—Syncope—Topiramate—migraine	9.96e-05	0.00101	CcSEcCtD
Sorafenib—Leukopenia—Topiramate—migraine	9.94e-05	0.00101	CcSEcCtD
Sorafenib—Pain—Timolol—migraine	9.9e-05	0.001	CcSEcCtD
Sorafenib—Musculoskeletal discomfort—Gabapentin—migraine	9.82e-05	0.000993	CcSEcCtD
Sorafenib—Loss of consciousness—Topiramate—migraine	9.76e-05	0.000988	CcSEcCtD
Sorafenib—Cough—Topiramate—migraine	9.69e-05	0.000981	CcSEcCtD
Sorafenib—Dyspnoea—Gabapentin—migraine	9.61e-05	0.000972	CcSEcCtD
Sorafenib—Hypertension—Topiramate—migraine	9.59e-05	0.00097	CcSEcCtD
Sorafenib—Hypersensitivity—Valproic Acid—migraine	9.58e-05	0.000969	CcSEcCtD
Sorafenib—Dyspepsia—Gabapentin—migraine	9.49e-05	0.00096	CcSEcCtD
Sorafenib—Gastrointestinal pain—Timolol—migraine	9.46e-05	0.000957	CcSEcCtD
Sorafenib—Myalgia—Topiramate—migraine	9.46e-05	0.000957	CcSEcCtD
Sorafenib—Arthralgia—Topiramate—migraine	9.46e-05	0.000957	CcSEcCtD
Sorafenib—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	9.39e-05	0.00095	CcSEcCtD
Sorafenib—Decreased appetite—Gabapentin—migraine	9.37e-05	0.000948	CcSEcCtD
Sorafenib—Asthenia—Valproic Acid—migraine	9.33e-05	0.000944	CcSEcCtD
Sorafenib—Gastrointestinal disorder—Gabapentin—migraine	9.3e-05	0.000941	CcSEcCtD
Sorafenib—Fatigue—Gabapentin—migraine	9.29e-05	0.00094	CcSEcCtD
Sorafenib—Dry mouth—Topiramate—migraine	9.25e-05	0.000936	CcSEcCtD
Sorafenib—Pain—Gabapentin—migraine	9.22e-05	0.000932	CcSEcCtD
Sorafenib—Constipation—Gabapentin—migraine	9.22e-05	0.000932	CcSEcCtD
Sorafenib—Pruritus—Valproic Acid—migraine	9.2e-05	0.000931	CcSEcCtD
Sorafenib—Urticaria—Timolol—migraine	9.19e-05	0.00093	CcSEcCtD
Sorafenib—Abdominal pain—Timolol—migraine	9.15e-05	0.000926	CcSEcCtD
Sorafenib—Body temperature increased—Timolol—migraine	9.15e-05	0.000926	CcSEcCtD
Sorafenib—HTR2C—brain—migraine	9.14e-05	0.0015	CbGeAlD
Sorafenib—Infection—Topiramate—migraine	9.01e-05	0.000911	CcSEcCtD
Sorafenib—Shock—Topiramate—migraine	8.92e-05	0.000902	CcSEcCtD
Sorafenib—Diarrhoea—Valproic Acid—migraine	8.89e-05	0.0009	CcSEcCtD
Sorafenib—Nervous system disorder—Topiramate—migraine	8.89e-05	0.0009	CcSEcCtD
Sorafenib—Thrombocytopenia—Topiramate—migraine	8.88e-05	0.000898	CcSEcCtD
Sorafenib—Gastrointestinal pain—Gabapentin—migraine	8.81e-05	0.000892	CcSEcCtD
Sorafenib—Skin disorder—Topiramate—migraine	8.81e-05	0.000891	CcSEcCtD
Sorafenib—Anorexia—Topiramate—migraine	8.64e-05	0.000874	CcSEcCtD
Sorafenib—ABCC4—brain—migraine	8.63e-05	0.00142	CbGeAlD
Sorafenib—Dizziness—Valproic Acid—migraine	8.6e-05	0.00087	CcSEcCtD
Sorafenib—HTR2B—brain—migraine	8.59e-05	0.00141	CbGeAlD
Sorafenib—Urticaria—Gabapentin—migraine	8.56e-05	0.000866	CcSEcCtD
Sorafenib—Hypersensitivity—Timolol—migraine	8.53e-05	0.000863	CcSEcCtD
Sorafenib—Abdominal pain—Gabapentin—migraine	8.52e-05	0.000862	CcSEcCtD
Sorafenib—Body temperature increased—Gabapentin—migraine	8.52e-05	0.000862	CcSEcCtD
Sorafenib—ABCB1—trigeminal ganglion—migraine	8.48e-05	0.00139	CbGeAlD
Sorafenib—Asthenia—Timolol—migraine	8.3e-05	0.00084	CcSEcCtD
Sorafenib—Vomiting—Valproic Acid—migraine	8.27e-05	0.000836	CcSEcCtD
Sorafenib—Musculoskeletal discomfort—Topiramate—migraine	8.26e-05	0.000836	CcSEcCtD
Sorafenib—Rash—Valproic Acid—migraine	8.2e-05	0.000829	CcSEcCtD
Sorafenib—Dermatitis—Valproic Acid—migraine	8.19e-05	0.000829	CcSEcCtD
Sorafenib—Pruritus—Timolol—migraine	8.19e-05	0.000828	CcSEcCtD
Sorafenib—Headache—Valproic Acid—migraine	8.14e-05	0.000824	CcSEcCtD
Sorafenib—Dyspnoea—Topiramate—migraine	8.08e-05	0.000818	CcSEcCtD
Sorafenib—Dyspepsia—Topiramate—migraine	7.98e-05	0.000807	CcSEcCtD
Sorafenib—Hypersensitivity—Gabapentin—migraine	7.94e-05	0.000803	CcSEcCtD
Sorafenib—Diarrhoea—Timolol—migraine	7.92e-05	0.000801	CcSEcCtD
Sorafenib—Decreased appetite—Topiramate—migraine	7.88e-05	0.000797	CcSEcCtD
Sorafenib—Gastrointestinal disorder—Topiramate—migraine	7.83e-05	0.000792	CcSEcCtD
Sorafenib—Fatigue—Topiramate—migraine	7.82e-05	0.000791	CcSEcCtD
Sorafenib—CYP2B6—head—migraine	7.76e-05	0.00127	CbGeAlD
Sorafenib—Constipation—Topiramate—migraine	7.75e-05	0.000784	CcSEcCtD
Sorafenib—Pain—Topiramate—migraine	7.75e-05	0.000784	CcSEcCtD
Sorafenib—Asthenia—Gabapentin—migraine	7.73e-05	0.000782	CcSEcCtD
Sorafenib—Nausea—Valproic Acid—migraine	7.72e-05	0.000781	CcSEcCtD
Sorafenib—Dizziness—Timolol—migraine	7.65e-05	0.000774	CcSEcCtD
Sorafenib—Pruritus—Gabapentin—migraine	7.62e-05	0.000771	CcSEcCtD
Sorafenib—ABCG2—cerebellum—migraine	7.5e-05	0.00123	CbGeAlD
Sorafenib—Gastrointestinal pain—Topiramate—migraine	7.41e-05	0.00075	CcSEcCtD
Sorafenib—Diarrhoea—Gabapentin—migraine	7.37e-05	0.000746	CcSEcCtD
Sorafenib—Vomiting—Timolol—migraine	7.36e-05	0.000744	CcSEcCtD
Sorafenib—CYP2B6—nervous system—migraine	7.36e-05	0.00121	CbGeAlD
Sorafenib—Rash—Timolol—migraine	7.3e-05	0.000738	CcSEcCtD
Sorafenib—Dermatitis—Timolol—migraine	7.29e-05	0.000738	CcSEcCtD
Sorafenib—Headache—Timolol—migraine	7.25e-05	0.000733	CcSEcCtD
Sorafenib—Urticaria—Topiramate—migraine	7.2e-05	0.000729	CcSEcCtD
Sorafenib—Abdominal pain—Topiramate—migraine	7.17e-05	0.000725	CcSEcCtD
Sorafenib—Body temperature increased—Topiramate—migraine	7.17e-05	0.000725	CcSEcCtD
Sorafenib—Dizziness—Gabapentin—migraine	7.13e-05	0.000721	CcSEcCtD
Sorafenib—CYP2B6—central nervous system—migraine	7.08e-05	0.00116	CbGeAlD
Sorafenib—Nausea—Timolol—migraine	6.87e-05	0.000695	CcSEcCtD
Sorafenib—Vomiting—Gabapentin—migraine	6.85e-05	0.000693	CcSEcCtD
Sorafenib—Rash—Gabapentin—migraine	6.8e-05	0.000687	CcSEcCtD
Sorafenib—Dermatitis—Gabapentin—migraine	6.79e-05	0.000687	CcSEcCtD
Sorafenib—Headache—Gabapentin—migraine	6.75e-05	0.000683	CcSEcCtD
Sorafenib—Hypersensitivity—Topiramate—migraine	6.68e-05	0.000676	CcSEcCtD
Sorafenib—Asthenia—Topiramate—migraine	6.51e-05	0.000658	CcSEcCtD
Sorafenib—Pruritus—Topiramate—migraine	6.41e-05	0.000649	CcSEcCtD
Sorafenib—Nausea—Gabapentin—migraine	6.4e-05	0.000648	CcSEcCtD
Sorafenib—CYP2C8—brain—migraine	6.27e-05	0.00103	CbGeAlD
Sorafenib—Diarrhoea—Topiramate—migraine	6.2e-05	0.000628	CcSEcCtD
Sorafenib—ABCB1—cardiovascular system—migraine	6.12e-05	0.001	CbGeAlD
Sorafenib—ABCG2—brain—migraine	6.09e-05	0.000999	CbGeAlD
Sorafenib—Dizziness—Topiramate—migraine	6e-05	0.000607	CcSEcCtD
Sorafenib—CYP2D6—head—migraine	5.76e-05	0.000945	CbGeAlD
Sorafenib—Vomiting—Topiramate—migraine	5.76e-05	0.000583	CcSEcCtD
Sorafenib—Rash—Topiramate—migraine	5.72e-05	0.000578	CcSEcCtD
Sorafenib—Dermatitis—Topiramate—migraine	5.71e-05	0.000578	CcSEcCtD
Sorafenib—Headache—Topiramate—migraine	5.68e-05	0.000575	CcSEcCtD
Sorafenib—CYP2B6—brain—migraine	5.62e-05	0.000921	CbGeAlD
Sorafenib—CYP3A4—nervous system—migraine	5.55e-05	0.00091	CbGeAlD
Sorafenib—CYP2D6—nervous system—migraine	5.47e-05	0.000896	CbGeAlD
Sorafenib—Nausea—Topiramate—migraine	5.39e-05	0.000545	CcSEcCtD
Sorafenib—CYP3A4—central nervous system—migraine	5.35e-05	0.000876	CbGeAlD
Sorafenib—CYP2D6—central nervous system—migraine	5.26e-05	0.000862	CbGeAlD
Sorafenib—CYP2D6—cerebellum—migraine	5.14e-05	0.000843	CbGeAlD
Sorafenib—CYP2D6—brain—migraine	4.18e-05	0.000685	CbGeAlD
Sorafenib—ABCB1—head—migraine	4.15e-05	0.00068	CbGeAlD
Sorafenib—ABCB1—nervous system—migraine	3.93e-05	0.000644	CbGeAlD
Sorafenib—ABCB1—central nervous system—migraine	3.79e-05	0.00062	CbGeAlD
Sorafenib—ABCB1—cerebellum—migraine	3.7e-05	0.000606	CbGeAlD
Sorafenib—ABCB1—brain—migraine	3.01e-05	0.000493	CbGeAlD
Sorafenib—RAF1—Signaling by GPCR—NPS—migraine	1.47e-05	0.000235	CbGpPWpGaD
Sorafenib—KIT—Innate Immune System—FOS—migraine	1.46e-05	0.000233	CbGpPWpGaD
Sorafenib—MAP3K7—Innate Immune System—FOS—migraine	1.46e-05	0.000233	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—HTR2C—migraine	1.44e-05	0.000231	CbGpPWpGaD
Sorafenib—RAF1—Integrated Pancreatic Cancer Pathway—TNF—migraine	1.44e-05	0.000231	CbGpPWpGaD
Sorafenib—HTR2B—Signaling by GPCR—CALCA—migraine	1.44e-05	0.00023	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—EDNRA—migraine	1.44e-05	0.00023	CbGpPWpGaD
Sorafenib—RAF1—Signaling by GPCR—HTR2C—migraine	1.44e-05	0.00023	CbGpPWpGaD
Sorafenib—CDK7—Gene Expression—ESR1—migraine	1.42e-05	0.000227	CbGpPWpGaD
Sorafenib—FGFR1—Disease—CALCA—migraine	1.42e-05	0.000227	CbGpPWpGaD
Sorafenib—HTR2C—GPCR downstream signaling—HTR1A—migraine	1.41e-05	0.000226	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—CALCA—migraine	1.41e-05	0.000226	CbGpPWpGaD
Sorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	1.4e-05	0.000224	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—NOTCH3—migraine	1.4e-05	0.000224	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—HTR2B—migraine	1.4e-05	0.000224	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—EDNRA—migraine	1.4e-05	0.000224	CbGpPWpGaD
Sorafenib—RAF1—Signaling by GPCR—EDNRA—migraine	1.4e-05	0.000224	CbGpPWpGaD
Sorafenib—HTR2C—GPCR downstream signaling—TAC1—migraine	1.39e-05	0.000223	CbGpPWpGaD
Sorafenib—HTR2C—GPCR downstream signaling—NPS—migraine	1.39e-05	0.000223	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—LRP1—migraine	1.38e-05	0.000222	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—CALCA—migraine	1.38e-05	0.000222	CbGpPWpGaD
Sorafenib—FGFR1—Innate Immune System—FOS—migraine	1.38e-05	0.000221	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—NOTCH4—migraine	1.38e-05	0.000221	CbGpPWpGaD
Sorafenib—PDGFRA—Innate Immune System—FOS—migraine	1.38e-05	0.000221	CbGpPWpGaD
Sorafenib—ABCB1—Allograft Rejection—TNF—migraine	1.38e-05	0.00022	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—NOTCH4—migraine	1.37e-05	0.000219	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—NOTCH3—migraine	1.37e-05	0.000219	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—CALCA—migraine	1.35e-05	0.000216	CbGpPWpGaD
Sorafenib—HTR2B—Signaling by GPCR—HTR7—migraine	1.35e-05	0.000216	CbGpPWpGaD
Sorafenib—RAF1—Signaling by GPCR—CALCA—migraine	1.35e-05	0.000215	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—HTR1B—migraine	1.33e-05	0.000214	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—HTR1B—migraine	1.33e-05	0.000213	CbGpPWpGaD
Sorafenib—HTR2C—GPCR downstream signaling—EDNRA—migraine	1.33e-05	0.000213	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—HTR2A—migraine	1.33e-05	0.000213	CbGpPWpGaD
Sorafenib—BRAF—Disease—TGFBR2—migraine	1.32e-05	0.000212	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—LRP1—migraine	1.32e-05	0.000211	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—HTR1B—migraine	1.32e-05	0.000211	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—ESR1—migraine	1.31e-05	0.00021	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—HTR1D—migraine	1.3e-05	0.000208	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—HTR7—migraine	1.29e-05	0.000207	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—HTR1A—migraine	1.28e-05	0.000206	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—HTR1A—migraine	1.28e-05	0.000205	CbGpPWpGaD
Sorafenib—HTR2C—GPCR downstream signaling—CALCA—migraine	1.28e-05	0.000205	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—CALCA—migraine	1.27e-05	0.000204	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—HTR1A—migraine	1.27e-05	0.000203	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—TAC1—migraine	1.26e-05	0.000202	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—NPS—migraine	1.26e-05	0.000202	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—TAC1—migraine	1.26e-05	0.000202	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—PGR—migraine	1.26e-05	0.000202	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—NPS—migraine	1.26e-05	0.000202	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—HTR7—migraine	1.26e-05	0.000202	CbGpPWpGaD
Sorafenib—RAF1—Signaling by GPCR—HTR7—migraine	1.26e-05	0.000201	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—TAC1—migraine	1.25e-05	0.0002	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—NPS—migraine	1.25e-05	0.0002	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—PGR—migraine	1.25e-05	0.0002	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—NOTCH4—migraine	1.25e-05	0.000199	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—NOTCH4—migraine	1.25e-05	0.000199	CbGpPWpGaD
Sorafenib—PDGFRB—Innate Immune System—FOS—migraine	1.24e-05	0.000199	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—HTR2C—migraine	1.24e-05	0.000198	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—LRP1—migraine	1.23e-05	0.000197	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—HTR2C—migraine	1.23e-05	0.000196	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—HTR2B—migraine	1.21e-05	0.000194	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—EDNRA—migraine	1.21e-05	0.000193	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—EDNRA—migraine	1.2e-05	0.000193	CbGpPWpGaD
Sorafenib—KIT—Disease—TGFBR2—migraine	1.2e-05	0.000193	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—CACNA1A—migraine	1.2e-05	0.000192	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—HTR1B—migraine	1.2e-05	0.000192	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—HTR1B—migraine	1.2e-05	0.000192	CbGpPWpGaD
Sorafenib—HTR2C—GPCR downstream signaling—HTR7—migraine	1.2e-05	0.000192	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—EDNRA—migraine	1.19e-05	0.000191	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—NOTCH4—migraine	1.18e-05	0.000189	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—NOTCH4—migraine	1.18e-05	0.000189	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—ESR1—migraine	1.18e-05	0.000189	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—CACNA1A—migraine	1.17e-05	0.000188	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—NOTCH3—migraine	1.17e-05	0.000188	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—NOTCH3—migraine	1.16e-05	0.000186	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—CALCA—migraine	1.16e-05	0.000186	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—CALCA—migraine	1.16e-05	0.000186	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—HTR1A—migraine	1.16e-05	0.000185	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—HTR1A—migraine	1.16e-05	0.000185	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—CALCA—migraine	1.15e-05	0.000184	CbGpPWpGaD
Sorafenib—KDR—Developmental Biology—TNF—migraine	1.14e-05	0.000183	CbGpPWpGaD
Sorafenib—FGFR1—Disease—TGFBR2—migraine	1.14e-05	0.000183	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—HTR1B—migraine	1.14e-05	0.000183	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—TAC1—migraine	1.14e-05	0.000182	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—NPS—migraine	1.14e-05	0.000182	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—TAC1—migraine	1.14e-05	0.000182	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—NPS—migraine	1.14e-05	0.000182	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—PGR—migraine	1.14e-05	0.000182	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—PGR—migraine	1.14e-05	0.000182	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—TGFBR2—migraine	1.14e-05	0.000182	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—HTR1B—migraine	1.14e-05	0.000182	CbGpPWpGaD
Sorafenib—RAF1—Disease—CALCA—migraine	1.14e-05	0.000182	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—HTR2C—migraine	1.12e-05	0.000179	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—HTR2C—migraine	1.12e-05	0.000179	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—TGFBR2—migraine	1.11e-05	0.000178	CbGpPWpGaD
Sorafenib—RAF1—Innate Immune System—FOS—migraine	1.11e-05	0.000177	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—HTR1A—migraine	1.1e-05	0.000176	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—HTR1A—migraine	1.09e-05	0.000175	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—HTR7—migraine	1.09e-05	0.000174	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—EDNRA—migraine	1.09e-05	0.000174	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—EDNRA—migraine	1.09e-05	0.000174	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—TGFBR2—migraine	1.09e-05	0.000174	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—HTR7—migraine	1.08e-05	0.000174	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—NPS—migraine	1.08e-05	0.000173	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—TAC1—migraine	1.08e-05	0.000173	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—PGR—migraine	1.08e-05	0.000173	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—NPS—migraine	1.08e-05	0.000173	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—PGR—migraine	1.08e-05	0.000173	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—TAC1—migraine	1.08e-05	0.000173	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—HTR7—migraine	1.07e-05	0.000172	CbGpPWpGaD
Sorafenib—BRAF—Disease—MTHFR—migraine	1.07e-05	0.000172	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—LRP1—migraine	1.06e-05	0.00017	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—NOTCH4—migraine	1.06e-05	0.00017	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—HTR2C—migraine	1.06e-05	0.00017	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—NOTCH3—migraine	1.06e-05	0.000169	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—NOTCH3—migraine	1.06e-05	0.000169	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—HTR2C—migraine	1.06e-05	0.000169	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—CALCA—migraine	1.05e-05	0.000167	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—CALCA—migraine	1.05e-05	0.000167	CbGpPWpGaD
Sorafenib—HTR2B—GPCR downstream signaling—HTR2A—migraine	1.04e-05	0.000166	CbGpPWpGaD
Sorafenib—MAPK11—Gene Expression—ESR1—migraine	1.04e-05	0.000166	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—EDNRA—migraine	1.03e-05	0.000165	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—EDNRA—migraine	1.03e-05	0.000165	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—TGFBR2—migraine	1.03e-05	0.000164	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—HTR1B—migraine	1.02e-05	0.000164	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—CACNA1A—migraine	1.02e-05	0.000163	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—NOTCH4—migraine	1.01e-05	0.000162	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—NOTCH3—migraine	1e-05	0.000161	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—NOTCH3—migraine	1e-05	0.00016	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—CALCA—migraine	9.92e-06	0.000159	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—CALCA—migraine	9.9e-06	0.000158	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—HTR1A—migraine	9.86e-06	0.000158	CbGpPWpGaD
Sorafenib—MAPK11—Developmental Biology—TNF—migraine	9.82e-06	0.000157	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—HTR7—migraine	9.78e-06	0.000157	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—HTR7—migraine	9.78e-06	0.000157	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—HTR1B—migraine	9.77e-06	0.000156	CbGpPWpGaD
Sorafenib—KIT—Disease—MTHFR—migraine	9.77e-06	0.000156	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—TAC1—migraine	9.71e-06	0.000155	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—NPS—migraine	9.71e-06	0.000155	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—PGR—migraine	9.71e-06	0.000155	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—HTR2C—migraine	9.52e-06	0.000152	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—NOTCH4—migraine	9.46e-06	0.000152	CbGpPWpGaD
Sorafenib—HTR2B—Signaling by GPCR—HTR2A—migraine	9.43e-06	0.000151	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—HTR1A—migraine	9.4e-06	0.000151	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—FOS—migraine	9.4e-06	0.00015	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—TGFBR2—migraine	9.34e-06	0.00015	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—HTR7—migraine	9.28e-06	0.000149	CbGpPWpGaD
Sorafenib—FGFR1—Disease—MTHFR—migraine	9.27e-06	0.000148	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—EDNRA—migraine	9.26e-06	0.000148	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—NPS—migraine	9.26e-06	0.000148	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—PGR—migraine	9.26e-06	0.000148	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—TAC1—migraine	9.26e-06	0.000148	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—HTR7—migraine	9.26e-06	0.000148	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—TGFBR2—migraine	9.25e-06	0.000148	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—MTHFR—migraine	9.25e-06	0.000148	CbGpPWpGaD
Sorafenib—RAF1—Disease—TGFBR2—migraine	9.14e-06	0.000146	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—HTR1B—migraine	9.13e-06	0.000146	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—CACNA1A—migraine	9.08e-06	0.000145	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—HTR2C—migraine	9.08e-06	0.000145	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—HTR2A—migraine	9.07e-06	0.000145	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—NOTCH3—migraine	9.03e-06	0.000145	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—CALCA—migraine	8.92e-06	0.000143	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—CACNA1A—migraine	8.87e-06	0.000142	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—EDNRA—migraine	8.84e-06	0.000141	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—HTR2A—migraine	8.84e-06	0.000141	CbGpPWpGaD
Sorafenib—RAF1—Signaling by GPCR—HTR2A—migraine	8.82e-06	0.000141	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—HTR1A—migraine	8.79e-06	0.000141	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—TAC1—migraine	8.66e-06	0.000139	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—NPS—migraine	8.66e-06	0.000139	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—PGR—migraine	8.66e-06	0.000139	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—NOTCH3—migraine	8.61e-06	0.000138	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—CALCA—migraine	8.5e-06	0.000136	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—HTR2C—migraine	8.49e-06	0.000136	CbGpPWpGaD
Sorafenib—KIT—Immune System—FOS—migraine	8.48e-06	0.000136	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—FOS—migraine	8.48e-06	0.000136	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—TGFBR2—migraine	8.42e-06	0.000135	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—TGFBR2—migraine	8.42e-06	0.000135	CbGpPWpGaD
Sorafenib—FGFR1—Developmental Biology—TNF—migraine	8.41e-06	0.000135	CbGpPWpGaD
Sorafenib—HTR2C—GPCR downstream signaling—HTR2A—migraine	8.38e-06	0.000134	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—CACNA1A—migraine	8.35e-06	0.000134	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—HTR7—migraine	8.34e-06	0.000134	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—MTHFR—migraine	8.33e-06	0.000133	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—CACNA1A—migraine	8.28e-06	0.000133	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—EDNRA—migraine	8.26e-06	0.000132	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—NOTCH4—migraine	8.17e-06	0.000131	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—ESR1—migraine	8.05e-06	0.000129	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—NOTCH3—migraine	8.05e-06	0.000129	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—FOS—migraine	8.04e-06	0.000129	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—FOS—migraine	8.02e-06	0.000128	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—TGFBR2—migraine	7.99e-06	0.000128	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—TGFBR2—migraine	7.97e-06	0.000128	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—HTR7—migraine	7.96e-06	0.000127	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—CALCA—migraine	7.95e-06	0.000127	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—HTR1B—migraine	7.88e-06	0.000126	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—ESR1—migraine	7.84e-06	0.000126	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—HTR2A—migraine	7.61e-06	0.000122	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—HTR2A—migraine	7.6e-06	0.000122	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—HTR1A—migraine	7.59e-06	0.000121	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—HTR2A—migraine	7.53e-06	0.00012	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—NPS—migraine	7.47e-06	0.00012	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—PGR—migraine	7.47e-06	0.00012	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—TAC1—migraine	7.47e-06	0.00012	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—HTR7—migraine	7.43e-06	0.000119	CbGpPWpGaD
Sorafenib—RAF1—Disease—MTHFR—migraine	7.43e-06	0.000119	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—FOS—migraine	7.23e-06	0.000116	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—TGFBR2—migraine	7.18e-06	0.000115	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—EDNRA—migraine	7.13e-06	0.000114	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—CACNA1A—migraine	7.08e-06	0.000113	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—NOTCH3—migraine	6.95e-06	0.000111	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—CALCA—migraine	6.86e-06	0.00011	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—TGFBR2—migraine	6.85e-06	0.00011	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—HTR2A—migraine	6.85e-06	0.00011	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—HTR2A—migraine	6.85e-06	0.00011	CbGpPWpGaD
Sorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—migraine	6.79e-06	0.000109	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—ESR1—migraine	6.74e-06	0.000108	CbGpPWpGaD
Sorafenib—RAF1—Developmental Biology—TNF—migraine	6.73e-06	0.000108	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—ESR1—migraine	6.68e-06	0.000107	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—HTR2A—migraine	6.5e-06	0.000104	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—HTR2A—migraine	6.49e-06	0.000104	CbGpPWpGaD
Sorafenib—RAF1—Immune System—FOS—migraine	6.44e-06	0.000103	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—HTR7—migraine	6.42e-06	0.000103	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—TGFBR2—migraine	6.4e-06	0.000103	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—MTHFR—migraine	6.39e-06	0.000102	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—MTHFR—migraine	6.39e-06	0.000102	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—ESR1—migraine	6.08e-06	9.73e-05	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—ESR1—migraine	6.08e-06	9.73e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—HTR2A—migraine	5.84e-06	9.35e-05	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—ESR1—migraine	5.77e-06	9.24e-05	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—ESR1—migraine	5.76e-06	9.21e-05	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—HTR2A—migraine	5.57e-06	8.92e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—TGFBR2—migraine	5.53e-06	8.85e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—CACNA1A—migraine	5.46e-06	8.74e-05	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—MTHFR—migraine	5.42e-06	8.68e-05	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—MTHFR—migraine	5.38e-06	8.61e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—HTR2A—migraine	5.21e-06	8.34e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—ESR1—migraine	5.19e-06	8.3e-05	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—ESR1—migraine	4.95e-06	7.92e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—ESR1—migraine	4.62e-06	7.4e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—HTR2A—migraine	4.5e-06	7.2e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—ESR1—migraine	3.99e-06	6.39e-05	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—MTHFR—migraine	3.98e-06	6.37e-05	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—MTHFR—migraine	3.89e-06	6.22e-05	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—MTHFR—migraine	3.37e-06	5.39e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—MTHFR—migraine	3e-06	4.81e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—MTHFR—migraine	2.93e-06	4.69e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—MTHFR—migraine	2.76e-06	4.42e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—MTHFR—migraine	2.74e-06	4.39e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—MTHFR—migraine	2.34e-06	3.75e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—MTHFR—migraine	1.81e-06	2.89e-05	CbGpPWpGaD
